Skip to main page content
U.S. flag

An official website of the United States government

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Search Results

3,866 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Atezolizumab and chemotherapy for advanced or recurrent endometrial cancer (AtTEnd): a randomised, double-blind, placebo-controlled, phase 3 trial.
Colombo N, Biagioli E, Harano K, Galli F, Hudson E, Antill Y, Choi CH, Rabaglio M, Marmé F, Marth C, Parma G, Fariñas-Madrid L, Nishio S, Allan K, Lee YC, Piovano E, Pardo B, Nakagawa S, McQueen J, Zamagni C, Manso L, Takehara K, Tasca G, Ferrero A, Tognon G, Lissoni AA, Petrella M, Laudani ME, Rulli E, Uggeri S, Barretina Ginesta MP; AtTEnd study group. Colombo N, et al. Among authors: nakagawa s. Lancet Oncol. 2024 Sep;25(9):1135-1146. doi: 10.1016/S1470-2045(24)00334-6. Epub 2024 Aug 2. Lancet Oncol. 2024. PMID: 39102832 Clinical Trial.
Prognostic impact of the number of resected pelvic nodes in endometrial cancer: Japanese Gynecologic Oncology Group Study JGOG2043 post hoc analysis.
Konno Y, Mayama M, Takehara K, Yokoyama Y, Suzuki J, Susumu N, Harano K, Nakagawa S, Nakanishi T, Yamagami W, Yoshihara K, Nomura H, Okamoto A, Aoki D, Watari H. Konno Y, et al. Among authors: nakagawa s. J Gynecol Oncol. 2024 Jun 3. doi: 10.3802/jgo.2025.36.e3. Online ahead of print. J Gynecol Oncol. 2024. PMID: 38857908 Free article.
CpG oligodeoxynucleotides potentiate the antitumor activity of anti-BST2 antibody.
Hiramatsu K, Serada S, Kobiyama K, Nakagawa S, Morimoto A, Matsuzaki S, Ueda Y, Fujimoto M, Yoshino K, Ishii KJ, Enomoto T, Kimura T, Naka T. Hiramatsu K, et al. Among authors: nakagawa s. Cancer Sci. 2015 Oct;106(10):1474-8. doi: 10.1111/cas.12738. Cancer Sci. 2015. PMID: 26498112 Free PMC article.
A nationwide birth year-by-year analysis of effectiveness of HPV vaccine in Japan.
Yagi A, Ueda Y, Nakagawa S, Masuda T, Miyatake T, Ikeda S, Abe H, Hirai K, Sekine M, Miyagi E, Enomoto T, Nakayama T, Kimura T. Yagi A, et al. Among authors: nakagawa s. Cancer Sci. 2021 Sep;112(9):3691-3698. doi: 10.1111/cas.15060. Epub 2021 Jul 22. Cancer Sci. 2021. PMID: 34252250 Free PMC article.
Cervical Cancer Protection in Japan: Where Are We?
Yagi A, Ueda Y, Kakuda M, Nakagawa S, Hiramatsu K, Miyoshi A, Kobayashi E, Kimura T, Kurosawa M, Yamaguchi M, Adachi S, Kudo R, Sekine M, Suzuki Y, Sukegawa A, Ikeda S, Miyagi E, Enomoto T, Kimura T. Yagi A, et al. Among authors: nakagawa s. Vaccines (Basel). 2021 Nov 1;9(11):1263. doi: 10.3390/vaccines9111263. Vaccines (Basel). 2021. PMID: 34835194 Free PMC article. Review.
Intentions for catch-up HPV vaccination in Japan: an internet survey.
Nakagawa S, Yagi A, Ueda Y, Ikeda S, Kakuda M, Hiramatsu K, Miyoshi A, Kimura T, Hirai K, Sekine M, Nakayama T, Kobayashi E, Miyagi E, Enomoto T, Kimura T. Nakagawa S, et al. Int J Clin Oncol. 2023 Dec;28(12):1667-1679. doi: 10.1007/s10147-023-02411-0. Epub 2023 Sep 30. Int J Clin Oncol. 2023. PMID: 37776388 Free PMC article.
3,866 results